Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

NCT07717437 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT07717437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07717437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Recruiting
Start date
March 16, 2021
Completion date
November 30, 2032
Enrollment
350 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, liver metastases